While the absence of PHD2 in endothelial cells appears to confer apparent metabolic benefits against obesity, systemic or endothelial-specific PHD2 deficiency also causes detrimental effects in the cardiopulmonary system. This evidence concerns the gene EGLN1 and obesity due to melanocortin 4 receptor deficiency.